You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
McKesson
Mallinckrodt
Baxter
Johnson and Johnson

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pyridoxamine-5'-Phosphate


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Pyridoxamine-5'-Phosphate?

Pyridoxamine-5'-Phosphate is an investigational drug.

There have been 6 clinical trials for Pyridoxamine-5'-Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2014.

The most common disease conditions in clinical trials are Kidney Diseases, Diabetic Nephropathies, and Nephrolithiasis. The leading clinical trial sponsors are Collaborative Study Group (CSG), BioStratum, and NephroGenex, Inc.

There are two US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Pyridoxamine-5'-Phosphate
TitleSponsorPhase
Advanced Glycation Endproducts and Bone Material Strength in T2D Treated With PyridoxamineColumbia UniversityN/A
Pyridorin in Diabetic NephropathyCollaborative Study Group (CSG)Phase 3
Pyridorin in Diabetic NephropathyMedpace, Inc.Phase 3

See all Pyridoxamine-5'-Phosphate clinical trials

Clinical Trial Summary for Pyridoxamine-5'-Phosphate

Top disease conditions for Pyridoxamine-5'-Phosphate
Top clinical trial sponsors for Pyridoxamine-5'-Phosphate

See all Pyridoxamine-5'-Phosphate clinical trials

US Patents for Pyridoxamine-5'-Phosphate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pyridoxamine-5'-Phosphate   Start Trial Methods and compositions for the topical treatment of peripheral neuropathy Jeffrey S. Brooks, Inc. (St. Louis, MO)   Start Trial
Pyridoxamine-5'-Phosphate   Start Trial Methods and compositions for enzyme linked immuno and hybridization mass spectrometric assay YYZ Pharmatech, Inc. (Toronto, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKesson
McKinsey
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.